Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) 3D Printed Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global 3D Printed Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Spritam
      • 1.3.3 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global 3D Printed Drugs Market Share by Application (2019-2025)
      • 1.4.2 Children
      • 1.4.3 Elderly
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global 3D Printed Drugs Market Size
      • 2.1.1 Global 3D Printed Drugs Revenue 2014-2025
      • 2.1.2 Global 3D Printed Drugs Sales 2014-2025
    • 2.2 3D Printed Drugs Growth Rate by Regions
      • 2.2.1 Global 3D Printed Drugs Sales by Regions 2014-2019
      • 2.2.2 Global 3D Printed Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 3D Printed Drugs Sales by Manufacturers
      • 3.1.1 3D Printed Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 3D Printed Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 3D Printed Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 3D Printed Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global 3D Printed Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 3D Printed Drugs Price by Manufacturers
    • 3.4 Key Manufacturers 3D Printed Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into 3D Printed Drugs Market
    • 3.6 Key Manufacturers 3D Printed Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Spritam Sales and Revenue (2014-2019)
      • 4.1.2 Others Sales and Revenue (2014-2019)
    • 4.2 Global 3D Printed Drugs Sales Market Share by Type
    • 4.3 Global 3D Printed Drugs Revenue Market Share by Type
    • 4.4 3D Printed Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global 3D Printed Drugs Sales by Application

    6 United States

    • 6.1 United States 3D Printed Drugs Breakdown Data by Company
    • 6.2 United States 3D Printed Drugs Breakdown Data by Type
    • 6.3 United States 3D Printed Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union 3D Printed Drugs Breakdown Data by Company
    • 7.2 European Union 3D Printed Drugs Breakdown Data by Type
    • 7.3 European Union 3D Printed Drugs Breakdown Data by Application

    8 China

    • 8.1 China 3D Printed Drugs Breakdown Data by Company
    • 8.2 China 3D Printed Drugs Breakdown Data by Type
    • 8.3 China 3D Printed Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World 3D Printed Drugs Breakdown Data by Company
    • 9.2 Rest of World 3D Printed Drugs Breakdown Data by Type
    • 9.3 Rest of World 3D Printed Drugs Breakdown Data by Application
    • 9.4 Rest of World 3D Printed Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World 3D Printed Drugs Sales by Countries
      • 9.4.2 Rest of World 3D Printed Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Aprecia Pharmaceuticals
      • 10.1.1 Aprecia Pharmaceuticals Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.1.4 3D Printed Drugs Product Introduction
      • 10.1.5 Aprecia Pharmaceuticals Recent Development
    • 10.2 GlaxoSmithKline Plc
      • 10.2.1 GlaxoSmithKline Plc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.2.4 3D Printed Drugs Product Introduction
      • 10.2.5 GlaxoSmithKline Plc Recent Development
    • 10.3 Hewlett Packard Caribe
      • 10.3.1 Hewlett Packard Caribe Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.3.4 3D Printed Drugs Product Introduction
      • 10.3.5 Hewlett Packard Caribe Recent Development
    • 10.4 BV
      • 10.4.1 BV Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.4.4 3D Printed Drugs Product Introduction
      • 10.4.5 BV Recent Development
    • 10.5 LLC
      • 10.5.1 LLC Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.5.4 3D Printed Drugs Product Introduction
      • 10.5.5 LLC Recent Development
    • 10.6 3D Printer Drug Machine
      • 10.6.1 3D Printer Drug Machine Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.6.4 3D Printed Drugs Product Introduction
      • 10.6.5 3D Printer Drug Machine Recent Development
    • 10.7 FabRx Ltd
      • 10.7.1 FabRx Ltd Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of 3D Printed Drugs
      • 10.7.4 3D Printed Drugs Product Introduction
      • 10.7.5 FabRx Ltd Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 3D Printed Drugs Sales Channels
      • 11.2.2 3D Printed Drugs Distributors
    • 11.3 3D Printed Drugs Customers

    12 Market Forecast

    • 12.1 Global 3D Printed Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global 3D Printed Drugs Sales Forecast by Type
    • 12.3 Global 3D Printed Drugs Sales Forecast by Application
    • 12.4 3D Printed Drugs Forecast by Regions
      • 12.4.1 Global 3D Printed Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global 3D Printed Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. 
      Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 
      In 2019, the market size of 3D Printed Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for 3D Printed Drugs.

      This report studies the global market size of 3D Printed Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the 3D Printed Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Aprecia Pharmaceuticals
      GlaxoSmithKline Plc
      Hewlett Packard Caribe
      BV
      LLC
      3D Printer Drug Machine
      FabRx Ltd
      ...

      Market Segment by Product Type
      Spritam
      Others

      Market Segment by Application
      Children
      Elderly
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the 3D Printed Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key 3D Printed Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of 3D Printed Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now